Oaktree Capital Management »

Bridgebio Pharma shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.9M 6.5M 0.75
2023-06-30 $4.5M 7.3M 0.62
2023-03-31 $2.6M 4.0M 0.65

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Chesapeake Energy Corp Common Stock (CHK)
Garrett Motion Common Stock (GTX)
Sitio Royalties Corp Common Stock (STR)
Star Bulk Carriers Corp Common Stock (SBLK)
Vistra Corp Common Stock (VST)
Runway Growth Finance Corp Common Stock (RWAY)
Spdr S&p Oil & Gas Exploration & Production Etf Etf Put Option (XOP)
Nmi Holdings Common Stock (NMIH)
Vale Sa Common Stock (VALE)
Caterpillar Common Stock Put Option (CAT)
Infinera Corp Common Stock (INFN)
Freeport-mcmoran Common Stock (FCX)
Petroleo Brasileiro Sa Common Stock (PBR)
Cemex Sab De Cv Common Stock (CX)

View all positions for Oaktree Capital Management

Top funds holding Bridgebio Pharma

Braidwell
Ubs Global Asset Management Americas
D. E. Shaw & Co
Weiss Asset Management LP[1
Aristeia Capital
Context Capital Management
Laurion Capital Management
Point72 Asset Management
DeepCurrents Investment Group
Diameter Capital Partners
Wells Fargo & Company
Aequim Alternative Investments
Segantii Capital Management
Calamos Advisors
Lord, Abbett & Co

View all funds holding Bridgebio Pharma